Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
24 hedge funds and large institutions have $4.11M invested in Celgene Corporation Contingent Value Rights in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
4% more funds holding
Funds holding: 23 → 24 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
18% less capital invested
Capital invested by funds: $5.04M → $4.11M (-$926K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Davenport & Co
Richmond,
Virginia
|
+$16.6K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$517 |
| 3 |
Citigroup
New York
|
+$277 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$55 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$453K |
| 2 |
Millennium Management
New York
|
-$89.4K |
| 3 |
WJA
Williams Jones & Associates
New York
|
-$31.8K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$4K |
| 5 |
State Street
Boston,
Massachusetts
|
-$55 |
CELGZ Hedge Fund Activity: Q2 2014 in Review
24 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q2 2014, worth a combined $4.11M — down 18% from $5.04M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CELGZ positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Davenport & Co, adding an estimated $16.6K. The largest seller was FCG Advisors, cutting an estimated $453K.
- 24 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q2 2014, up from 23 in Q1 2014.
- Funds reported $4.11M of Celgene Corporation Contingent Value Rights stock for Q2 2014, down 18% quarter-over-quarter.
- 2 funds opened new Celgene Corporation Contingent Value Rights positions in Q2 2014 and 1 closed out, a net change of +1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q2 2014 was Davenport & Co, an estimated $16.6K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q2 2014 was FCG Advisors, an estimated $453K sold.
Based on aggregated 13F filings for Q2 2014.